A van der Gaast Selected Research

laniquidar (R101933)

5/2002	Disposition of docetaxel in the presence of P-glycoprotein inhibition by intravenous administration of R101933.
4/2000	The orally administered P-glycoprotein inhibitor R101933 does not alter the plasma pharmacokinetics of docetaxel.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

A van der Gaast Research Topics

Disease

24	Neoplasms (Cancer) 01/2021 - 02/2000
7	Carcinoma (Carcinomatosis) 12/2019 - 11/2001
4	Neoplasm Metastasis (Metastasis) 03/2015 - 12/2003
4	Deglutition Disorders (Dysphagia) 12/2005 - 11/2001
3	Esophageal Neoplasms (Esophageal Cancer) 12/2017 - 10/2004
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2003 - 02/2000
2	Adenocarcinoma 01/2017 - 11/2008
2	Neutropenia 05/2012 - 01/2005
2	Fatigue 05/2012 - 09/2010
2	Anorexia 05/2012 - 09/2010
2	Fever (Fevers) 01/2005 - 04/2000
2	Sleepiness 01/2005 - 05/2002
2	Thrombocytopenia (Thrombopenia) 12/2002 - 04/2002
2	Mucositis 04/2002 - 04/2000
1	Margins of Excision 05/2012
1	Leukopenia 05/2012
1	Stomach Neoplasms (Stomach Cancer) 12/2010
1	Nausea 09/2010
1	Exanthema (Rash) 09/2010
1	Vomiting 09/2010
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 11/2008
1	Ovarian Neoplasms (Ovarian Cancer) 11/2005
1	Lymphatic Metastasis 12/2003
1	Weight Loss (Weight Reduction) 12/2003
1	Renal Cell Carcinoma (Grawitz Tumor) 04/2002
1	Fistula 11/2001
1	Colorectal Neoplasms (Colorectal Cancer) 06/2000
1	Body Weight (Weight, Body) 02/2000

Drug/Important Bio-Agent (IBA)

6	Cisplatin (Platino)FDA LinkGeneric 12/2010 - 03/2002
5	Paclitaxel (Taxol)FDA LinkGeneric 05/2012 - 03/2002
3	Carboplatin (JM8)FDA LinkGeneric 05/2012 - 11/2005
2	Capecitabine (Xeloda)FDA Link 12/2010 - 05/2007
2	MetalsIBA 10/2004 - 11/2001
2	Etoposide (VP 16)FDA LinkGeneric 12/2003 - 03/2003
2	laniquidar (R101933)IBA 05/2002 - 04/2000
1	Pravastatin (Pravachol)FDA LinkGeneric 12/2010
1	Epirubicin (Ellence)FDA LinkGeneric 12/2010
1	JNJ-26483327IBA 09/2010
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 05/2007
1	ElementsIBA 08/2006
1	NAc- Sar- Gly- Val- (d- allo- Ile)- Thr- Nva- Ile- Arg- ProNEt (ABT 510)IBA 08/2006
1	Angiogenesis InhibitorsIBA 08/2006
1	Gemcitabine FDA Link 08/2006
1	PlatinumIBA 11/2005
1	ElacridarIBA 01/2005
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2005
1	adriamycinolIBA 01/2005
1	N 30IBA 10/2004
1	Alkaline PhosphataseIBA 12/2003
1	Fluorouracil (Carac)FDA LinkGeneric 12/2003
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 12/2003
1	4- demethoxy- 3'- deamino- 3'- aziridinyl- 4'- methylsulfonyldaunorubicinIBA 12/2002
1	Interferon-alpha (Interferon Alfa)IBA 04/2002
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 04/2002
1	methotrexate-serum albuminIBA 04/2002
1	Transaminases (Aminotransferases)IBA 04/2002
1	LipidsIBA 07/2000
1	Fatty Acids (Saturated Fatty Acids)IBA 07/2000
1	PalmitatesIBA 07/2000
1	Glycerol (Glycerine)FDA LinkGeneric 07/2000
1	triphosphoric acid (triphosphate)IBA 06/2000
1	DNA (Deoxyribonucleic Acid)IBA 06/2000
1	Docetaxel (Taxotere)FDA Link 04/2000
1	AlbuminsIBA 02/2000
1	Adenosine Triphosphate (ATP)IBA 02/2000
1	Adenosine (Adenocard)FDA LinkGeneric 02/2000

Therapy/Procedure

10	Neoadjuvant Therapy 01/2021 - 11/2008
5	Drug Therapy (Chemotherapy) 12/2010 - 12/2005
4	Radiotherapy 05/2012 - 12/2005
4	Therapeutics 05/2007 - 03/2003
4	Stents 12/2005 - 11/2001
3	Chemoradiotherapy 10/2018 - 11/2008
3	Palliative Care (Palliative Therapy) 08/2006 - 10/2004
2	Aftercare (After-Treatment) 11/2008 - 04/2002
2	Combination Drug Therapy (Combination Chemotherapy) 11/2005 - 12/2003
1	Esophagectomy 12/2019
1	Combined Modality Therapy 07/2016
1	Induction Chemotherapy 03/2015
1	Brachytherapy 12/2005
1	Immunotherapy 04/2002
1	Nephrectomy 04/2002
1	Gastrectomy 11/2001
1	Oral Administration 06/2000